Daniel Kwaku Abankwa (Daniel Abankwa)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 30

Top Topics

Ankylosing Spondylitis

Top Venues

Nature communications

Biochemical Society transactions

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Candy Laura Steffen, Ganesh Babu Manoharan, Karolina Pavic, Alejandro Yeste-Vázquez, Matias Knuuttila, Neha Arora, Yong Zhou, Harri Härmä, Anthoula Gaigneaux, Tom N Grossmann, Daniel Kwaku Abankwa
Identification of an H-Ras nanocluster disrupting peptide. Communications biology 7 (1) (2024)
Candy Laura Steffen, Ganesh Babu Manoharan, Karolina Pavic, Alejandro Yeste-Vázquez, Matias Knuuttila, Neha Arora, Yong Zhou, Harri Härmä, Anthoula Gaigneaux, Tom N Grossmann, Daniel Kwaku Abankwa
Identification of an H-Ras nanocluster disrupting peptide. Communications biology 7 (1) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry 67 (11) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry 67 (11) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry 67 (11) (2024)
Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan, Vladimir Vukic, Alexandros Kiriazis, Mirko Ledda, Maria Burgos Renedo, Karolina Pavic, Anthoula Gaigneaux, Enrico Glaab, Daniel Kwaku Abankwa
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth. Journal of medicinal chemistry (2024)
Johanna Lilja, Jasmin Kaivola, James R W Conway, Joni Vuorio, Hanna Parkkola, Pekka Roivas, Michal Dibus, Megan R Chastney, Taru Varila, Guillaume Jacquemet, Emilia Peuhu, Emily Wang, Ulla Pentikäinen, Itziar Martinez D Posada, Hellyeh Hamidi, Arafath K Najumudeen, Owen James Sansom, Igor L Barsukov, Daniel Kwaku Abankwa, Ilpo Vattulainen, Marko Salmi, Johanna Ivaska
SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers. Nature communications 15 (1) (2024)
Candy Laura Steffen, Ganesh Babu Manoharan, Karolina Pavic, Alejandro Yeste-Vázquez, Matias Knuuttila, Neha Arora, Yong Zhou, Harri Härmä, Anthoula Gaigneaux, Tom N Grossmann, Daniel Kwaku Abankwa
Identification of an H-Ras nanocluster disrupting peptide. Communications biology 7 (1) (2024)
Karolina Pavic, Nikhil Gupta, Judit Domènech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A Määttä, Nico Höfflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Kwaku Abankwa, Maja Köhn, Vesa Pekka Hytönen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. Nature communications 14 (1) (2023)
Karolina Pavic, Nikhil Gupta, Judit Domènech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A Määttä, Nico Höfflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Kwaku Abankwa, Maja Köhn, Vesa Pekka Hytönen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. Nature communications 14 (1) (2023)
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, Daniel Kwaku Abankwa
Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society transactions 51 (1) (2023)
Ganesh Babu Manoharan, Christina Laurini, Sara Bottone, Nesrine Ben Fredj, Daniel Kwaku Abankwa
K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness. Cancers 15 (12) (2023)
Karolina Pavic, Nikhil Gupta, Judit Domènech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A Määttä, Nico Höfflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Kwaku Abankwa, Maja Köhn, Vesa Pekka Hytönen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. Nature communications 14 (1) (2023)
Karolina Pavic, Nikhil Gupta, Judit Domènech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A Määttä, Nico Höfflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Kwaku Abankwa, Maja Köhn, Vesa Pekka Hytönen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. Nature communications 14 (1) (2023)
Ganesh Babu Manoharan, Christina Laurini, Sara Bottone, Nesrine Ben Fredj, Daniel Kwaku Abankwa
K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness. Cancers 15 (12) (2023)
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, Daniel Kwaku Abankwa
Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society transactions (2023)
Karolina Pavic, Nikhil Gupta, Judit Domènech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A Määttä, Nico Höfflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Kwaku Abankwa, Maja Köhn, Vesa Pekka Hytönen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. Nature communications 14 (1) (2023)
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, Daniel Kwaku Abankwa
Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society transactions 51 (1) (2023)
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, Daniel Kwaku Abankwa
Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society transactions 51 (1) (2023)
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner-Reckinger, Daniel Kwaku Abankwa
Eliminating oncogenic RAS: back to the future at the drawing board. Biochemical Society transactions 51 (1) (2023)
Claudia Cipriani, Maria Pires Pacheco, Ali Kishk, Maryem Wachich, Daniel Kwaku Abankwa, Elisabeth Schaffner-Reckinger, Thomas Sauter
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Ganesh Babu Manoharan, Sunday Okutachi, Daniel Kwaku Abankwa
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells. PloS one 17 (5) (2022)
Farid Ahmad Siddiqui, Hanna Parkkola, Vladimir Vukić, Christina Oetken-Lindholm, Alok Jaiswal, Alexandros Kiriazis, Karolina Pavic, Tero Aittokallio, Tiina A Salminen, Daniel Kwaku Abankwa
Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling. Cancers 13 (4) (2021)
Enrico Glaab, Ganesh Babu Manoharan, Daniel Kwaku Abankwa
Pharmacophore Model for SARS-CoV-2 3CLpro Small-Molecule Inhibitors and in Vitro Experimental Validation of Computationally Screened Inhibitors. Journal of chemical information and modeling 61 (8) (2021)
Ian M Ahearn, Helen R Court, Farid A Siddiqui, Daniel Kwaku Abankwa, Mark R Philips
NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane. Life science alliance 4 (5) (2021)
Farid A Siddiqui, Vladimir Vukić, Tiina A Salminen, Daniel Kwaku Abankwa
Elaiophylin Is a Potent Hsp90/ Cdc37 Protein Interface Inhibitor with K-Ras Nanocluster Selectivity. Biomolecules 11 (6) (2021)
Daniel Kwaku Abankwa, Alemayehu Abebe Gorfe
Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again. Biomolecules 10 (11) (2020)
Itziar M D Posada, Benoit Lectez, Farid A Siddiqui, Christina Oetken-Lindholm, Mukund Sharma, Daniel Kwaku Abankwa
Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1. Scientific reports 7 (1) (2017)
Itziar M D Posada, Marc Serulla, Yong Zhou, Christina Oetken-Lindholm, Daniel Kwaku Abankwa, Benoît Lectez
ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold. PloS one 11 (7) (2016)
Elina Siljamäki, Daniel Kwaku Abankwa
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling. Molecular and cellular biology 36 (20) (2016)